Skip to main content
PepStack
Blutwerte · Marker

ACTH

Adrenocorticotropin · Adrenocorticotropes Hormon · Corticotropin

Hormone — StressachseZeitabhängig
Einheit:
pg/mL

ACTH quantifies the level of adrenocorticotropic hormone in the blood, reflecting pituitary function and adrenal stimulation.

Reference Ranges

Reference
7.263.3pg/mL
7.2
63.3
LowNormalHigh
Reference
Unit · pg/mL

ACTH levels are influenced by circadian rhythms, peaking in the early morning and declining throughout the day.

Overview

Übersicht

Adrenocorticotropic hormone (ACTH) is a peptide hormone produced by the anterior pituitary gland. It plays a crucial role in the hypothalamus-pituitary-adrenal (HPA) axis by stimulating the adrenal cortex to produce glucocorticoids, primarily cortisol, which is vital for stress response, metabolism, and immune function. Clinically, ACTH is significant in diagnosing disorders of the adrenal and pituitary glands. Elevated levels may indicate conditions such as Cushing's disease, where there is excessive production of cortisol due to pituitary adenomas secreting ACTH. Conversely, low levels can be indicative of secondary adrenal insufficiency or hypopituitarism. In the context of athletic performance and biohacking, ACTH and its downstream effects on cortisol can influence energy metabolism, recovery, and stress resilience. However, researchers found that interpreting ACTH levels can be complex due to factors such as diurnal variation, stress, and concurrent medications. Therefore, it is essential to consider these variables when assessing ACTH levels, as they can confound the results and lead to misinterpretation.

Klinische Bedeutung

Elevated ACTH levels may indicate Cushing's disease or ectopic ACTH syndrome, while low levels suggest secondary adrenal insufficiency or hypopituitarism.

Dynamics

Trend Interpretation

Rising Values

Progressively rising ACTH levels may suggest worsening of conditions like Cushing's disease. Retesting is recommended within 4-6 weeks.

Falling Values

Falling ACTH levels could indicate improvement in conditions like Cushing's disease or response to treatment.

Re-test Interval

4-6 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Cushing's disease
  • Ectopic ACTH syndrome
  • Adrenal insufficiency
  • Stress
  • Pituitary adenoma
Cause

Low Levels

  • Secondary adrenal insufficiency
  • Hypopituitarism
  • Exogenous glucocorticoid use
  • Adrenal adenoma
  • Pituitary damage
Protocol

How to Optimize

Lever

Lifestyle

  • Manage stress through mindfulness or meditation
  • Ensure adequate sleep
  • Regular physical activity
  • Avoid excessive alcohol consumption
Lever

Nutrition

  • Maintain a balanced diet
  • Include foods rich in vitamin C
  • Ensure adequate protein intake
  • Limit caffeine intake

Note:

Consult a healthcare provider before making significant lifestyle or dietary changes, especially if underlying health conditions are present.

Testing Guidelines

Fasting Not Required
🕐Time-Sensitive

ACTH levels peak in the early morning; testing is often done at this time for consistency.

Testing Frequency

Annually for those with adrenal or pituitary disorders, or as directed by a healthcare provider.

Interfering Factors

  • Recent intense exercise
  • Stress
  • Medications affecting cortisol
  • Time of day

Related Peptides & Hormones

Cortisol

Directly measures

hormone

Open Research Questions

Current research suggests that the relationship between salivary cortisol and plasma ACTH levels lacks a consistent linearity, indicating potential confounders that remain understudied, particularly in psychological stress contexts. Researchers have not yet established optimal reference ranges for ACTH in various conditions, such as ectopic Cushing's syndrome. Additionally, clinical questions regarding the best methods for monitoring ACTH levels post-surgery and the impact of psychological factors on ACTH responses remain unanswered.

26 Research Publications

8,303

Total Citations

3

Human/RCT

81.6

Avg. Influence

2023

Latest

Sort
Filter
#01

Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research.

Meta-AnalysisInfluence481.0
5856
This meta-analysis reviewed the effects of acute psychological stressors on cortisol levels, finding that tasks perceived as uncontrollable or socially evaluative elicited the largest cortisol and ACTH responses. Researchers observed significant variability in cortisol responses based on task characteristics.
View on PubMed
#02

Salivary cortisol as a biomarker in stress research.

ReviewInfluence51.0
1868
Researchers found that salivary cortisol is commonly used as a biomarker for psychological stress, but its relationship with plasma ACTH and cortisol levels is not always linear. The study discusses various biological and psychological factors that may affect salivary cortisol measures.
View on PubMed
#03

Pathophysiology of hypercortisolism in depression.

UnknownInfluence21.0
267
This study investigated the dynamics of ACTH and cortisol in depressed patients, finding that hypercortisolemia is associated with melancholic and psychotic subtypes. Researchers noted increased ACTH secretion regardless of cortisol levels, indicating central HPA axis overdrive in severe depression.
View on PubMed
#04

Response of the hypothalamo-pituitary-adrenal axis to nicotine.

ReviewInfluence13.0
145
Researchers reviewed the effects of nicotine on ACTH secretion, finding that nicotine stimulates the HPA axis through central mechanisms. The study highlighted the role of brainstem catecholaminergic pathways in mediating this response, suggesting a complex interaction.
View on PubMed
#05

Cushing's disease.

Review
59
This study focused on Cushing's disease, characterized by excessive ACTH secretion from the pituitary gland. Researchers found that initial diagnosis involves documenting hypercortisolism, followed by identifying the underlying cause, often requiring surgical intervention.
View on PubMed
#06

Canine hypoadrenocorticism: pathogenesis, diagnosis, and treatment.

ReviewInfluence3.0
56
This study examined hypoadrenocorticism in dogs, a rare condition caused by immune-mediated adrenal gland destruction. Researchers found that definitive diagnosis requires ACTH stimulation testing to demonstrate low cortisol levels, and many dogs may present with normal serum electrolytes despite showing various clinical symptoms.
View on PubMed
#07

Cushing’s disease and melancholia.

Review
13
This study explored the similarities between Cushing's disease and melancholic depression, noting shared laboratory abnormalities such as elevated cortisol and ACTH levels. Researchers emphasized the need for dynamic endocrine tests to differentiate between the two conditions.
View on PubMed
#08

Diagnosis of equine pituitary pars intermedia dysfunction.

Review
11
Researchers examined equine pituitary pars intermedia dysfunction (PPID), emphasizing the importance of basal ACTH concentration for diagnosis. The study found that combining clinical judgment with diagnostic testing improves accuracy in identifying this condition in aged horses.
View on PubMed
#09

Effect of CRF, ACTH and adrenal steroids on sodium intake and excretion of rabbits.

In VitroInfluence1.0
8
Researchers studied the effects of CRF, ACTH, and adrenal steroids on sodium intake and excretion in rabbits. They found that intracerebroventricular infusion of CRF increased sodium turnover, indicating a complex interaction with ACTH and adrenal hormones.
View on PubMed
#10

Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases.

ReviewInfluence1.0
8
Researchers conducted a structured review of 94 cases of ACTH-producing pheochromocytomas/paragangliomas. They found that these tumors co-secrete catecholamines and ACTH, leading to significant morbidity, with most patients achieving a cure after surgical intervention.
View on PubMed

Clinical Trials (9)

9

Total Trials

563

Total Enrolled

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

NCT07463625RECRUITING
Sponsor

Hospices Civils de Lyon

Enrollment

20

Started

2023

Primary outcome

[18F]FET PET Performance for Localizing Corticotroph Pituitary Adenomas

Cushing DiseaseACTH-producing Pituitary Tumour

Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy

NCT04609033COMPLETED
Sponsor

Assiut University

Enrollment

110

Started

2020

Primary outcome

postoperative level of ACTH hormone

Perioperative Pain

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

NCT05546047Phase 4UNKNOWN
Sponsor

NephroNet, Inc.

Enrollment

34

Started

2019

Primary outcome

The change in UP/CR ratio with treatment of Acthar gel 80 units subcutaneous 2 times a week alone

Fibrillary Glomerulonephritis

Treatment of CNS Sarcoidosis With H.P. Acthar Gel

NCT02298491Phase 4COMPLETED
Sponsor

University of Maryland, Baltimore

Enrollment

4

Started

2016

Primary outcome

Karnofsky Performance Status (KPS) Score

CNS Sarcoidosis

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

NCT01601236Phase 2COMPLETED
Sponsor

Mallinckrodt

Enrollment

34

Started

2012

Primary outcome

Percent Change in Estimated Glomerular Filtration Rate (eGFR) at Visit 12

Diabetic Nephropathy

Stress Level and the Relationship With IVF Outcomes.

NCT02638662COMPLETED
Sponsor

Weill Medical College of Cornell University

Enrollment

276

Started

2010

Primary outcome

Biomarkers Cortisol and adrenocorticotropic hormone ACTH.

Infertility

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

NCT00704262Phase 2COMPLETED
Sponsor

LEO Pharma

Enrollment

33

Started

2008

Primary outcome

The Adrenal Response to the ACTH Challenge Test Defined as the Serum Cortisol Concentration Obtained After 30 and 60 Minutes

Psoriasis Vulgaris

Remifentanil and Stress Hormones Response

NCT03378674COMPLETED
Sponsor

Catholic University of the Sacred Heart

Enrollment

50

Started

2008

Primary outcome

ACTH levels changes

Stress Response

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

NCT00612066Phase 2TERMINATED
Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

2

Started

2007

Primary outcome

Number of Responders

Cushing's Disease

Publication Trend

Research publications about ACTH over time

9total
1
'87
1
'98
1
'01
1
'04
1
'07
1
'09
1
'14
1
'22
1
'23

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer